PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,961 | -90.7% | 8,350 | -89.1% | 0.00% | -100.0% |
| Q1 2023 | $236,957 | -1.1% | 76,685 | +35.4% | 0.00% | 0.0% |
| Q4 2022 | $239,536 | +280.2% | 56,628 | +113.3% | 0.00% | – |
| Q3 2022 | $63,000 | -25.0% | 26,545 | -9.4% | 0.00% | -100.0% |
| Q2 2022 | $84,000 | -80.0% | 29,310 | -36.0% | 0.00% | -80.0% |
| Q2 2021 | $420,000 | +69.4% | 45,777 | +92.7% | 0.01% | +25.0% |
| Q2 2020 | $248,000 | – | 23,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |